- Home
- CRNX vs IRT Comparison
CRNX vs IRT Comparison
Compare CRNX & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | IRT |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.9B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CRNX | IRT |
|---|---|---|
| Price | $48.27 | $17.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $71.00 | $21.56 |
| AVG Volume (30 Days) | 992.2K | ★ 2.7M |
| Earning Date | 11-06-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $1,535,000.00 | ★ $662,924,000.00 |
| Revenue This Year | $425.41 | $4.21 |
| Revenue Next Year | $943.30 | $4.79 |
| P/E Ratio | ★ N/A | $192.27 |
| Revenue Growth | ★ 47.74 | 3.19 |
| 52 Week Low | $24.10 | $15.07 |
| 52 Week High | $54.18 | $21.87 |
Technical Indicators
Market Signals| Indicator | CRNX | IRT |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 63.51 |
| Support Level | $43.04 | $16.65 |
| Resistance Level | $49.61 | $17.28 |
| Average True Range (ATR) | 2.04 | 0.27 |
| MACD | -0.16 | 0.04 |
| Stochastic Oscillator | 62.22 | 98.29 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.